Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 6,941–6,960 of 18,020 recalls

FDA Recall Terminated Historical recordClass II

Soft Whisper by Powerstick Dandruff Shampoo (Pyrithione Zinc), 14.4 FL OZ. (426 mL), A.P. Deauville LLC New Brunswick, NJ 08901, NDC 42913-020-00, UPC 815195014097

by A.P. Deauville, LLC

Reason
cGMP Deviations: Soft Whisper Dandruff Shampoo was produced with water that failed USP specifications.
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350

by QuVa Pharma, Inc.

Reason
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, a) 100 (NDC 62037-577-01) and b) 1000 (NDC 62037-577-10), Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ

by Teva Pharmaceuticals USA

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Published
July 1, 2020
Distribution
Product was distributed throughout the U…

View recall →

FDA Recall Terminated Historical recordClass II

Metformin Hydrochloride Extended - Release Tablets, USP, 500 mg, a) 100 (NDC 62037-571-01) and b) 1,000 (NDC 62037-571-10) count bottles, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ

by Teva Pharmaceuticals USA

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Published
July 1, 2020
Distribution
Product was distributed throughout the U…

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Curcumin 50mg/mL, 10 mL vial

by BIOTA Biosciences LLC

Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Cannabidiol (CBD) + Curcumin 50mg/mL, 10 mL vial

by BIOTA Biosciences LLC

Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Cannabidiol (CBD) 50mg/mL, 10mL vial

by BIOTA Biosciences LLC

Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Curcumin, 4mg/mL, 10mL vial

by BIOTA Biosciences LLC

Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial

by BIOTA Biosciences LLC

Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

NOW Health Group Inc.

Product
NOW Real Food Raw Macadamia Nuts Unsalted 8 oz retail bag…
Reason
The product tested positive for Salmonella enterica.
Published
July 1, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Olanzapine Tablets, USP 7.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-682-30

by Aurobindo Pharma USA Inc.

Reason
Failed Impurities/ Degradation Specifications
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-680-30

by Aurobindo Pharma USA Inc.

Reason
Failed Impurities/ Degradation Specifications
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

EcoLips Sport Lip Balm, SPF 30, Avobenzone (5%), Octinoxate (10%), Octisalate (5%), Net Wt. 0.15 oz. (4.25g) tube, Eco Lips, Inc., Marion, IA 52302, UPC: 859623000030; 859623000177; 859623000573; Display UPC: 859623000092; 859623000108; 859623000139; 859623000146; 859623000184; 859623000535; 859623001037.

by Eco Lips Inc

Reason
Superpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01

by Hikma Pharmaceuticals USA Inc.

Reason
Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01

by Hikma Pharmaceuticals USA Inc.

Reason
Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
Published
June 24, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 50 count (NDC 50268-531-15); b) 90 count (NDC 42291-610-90); c) 180 count (NDC 42291-610-18); d) 360 count (NDC 42291-610-36); e) 1000 count (NDC 42291-610-10) bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Published
June 24, 2020
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.